arrow
S

Silvio Borrelli

university of campania luigi vanvitelli
H指数:33
被引数:3,833

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PolyCore, a bimodal peritoneal dialysis solution based on xylitol, L-carnitine, and icodextrin: In vitro evidence of the peritoneal membrane protection, rationale, and design of the phase II pilot study EXCITE

基于木糖醇、L-肉碱和艾考糊精的双模态腹膜透析液PolyCore:体外证据显示其对腹膜膜的保护作用、原理及II期试点研究EXCITE的设计

2026-10-080
PRE
One-Year Nutritional and Metabolic Changes in Patients on Incremental Peritoneal Dialysis Under Different Protein Diets: A Multicenter Pragmatic Cohort Study

不同蛋白饮食下增量腹膜透析患者一年营养与代谢变化:一项多中心实用队列研究

2026-08-110
OA
Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease

人白蛋白增强型腹膜透析:一种管理失代偿期晚期慢性肝病难治性腹水和肾功能不全的新型方法

2025-12-010
OA
Synbiotic Supplementation for Chronic Constipation in Patients under Peritoneal Dialysis: An Italian Multicenter Prospective Study

合生元补充剂对腹膜透析患者慢性便秘的治疗:一项意大利多中心前瞻性研究

2025-10-240
OAAI
Rationale and study design of EXCITE, a pilot study to evaluate safety and efficacy of PolyCore, a ternary combination of xylitol, L-carnitine and polydextrIn, to treat end-stage kidney disease patients starting peritoneal dialysis

EXCITE研究的原理与方案设计,一项旨在评估PolyCore(一种由木糖醇、L-肉碱和聚糊精组成的二元组合物)治疗开始腹膜透析的终末期肾病患者的安全性与有效性的试点研究。

2025-10-010
OA
Integrated conservative therapy-low dose peritoneal dialysis in patients with severe CKD (I-COPE CKD): multicentre prospective controlled study in Italian Nephrology Units

I-COPE CKD研究:重度慢性肾脏病患者整合保守治疗联合低剂量腹膜透析的多中心前瞻性对照研究(意大利肾脏病中心)

2025-10-010
OAAI
Successful use of glucagon-like peptide-1 receptor agonists (GLP1-RA) in a patient with obesity and diabetic kidney disease under peritoneal dialysis: a Case Report

成功使用胰高血糖素样肽-1受体激动剂(GLP1-RA)治疗一名合并肥胖和糖尿病肾病的腹膜透析患者:病例报告

2025-10-010
PRE
Synbiotic supplementation for chronic constipation in patients under peritoneal dialysis: an italian multicenter prospective study

合生元补充剂治疗腹膜透析患者慢性便秘:一项意大利多中心前瞻性研究

2025-10-010
PRE
Efficacy and safety of dapagliflozin in patients with CKD: real-world experience in 93 Italian renal clinics

达格列净对慢性肾脏病患者的疗效和安全性: 93家意大利肾脏诊所的真实经验

2024-12-030
OAAI
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study
2024-10-170
OAAI